• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Duration of cardiac effects of timolol and propranolol.

作者信息

Achong M R, Piafsky K M, Ogilvie R I

出版信息

Clin Pharmacol Ther. 1976 Feb;19(2):148-52. doi: 10.1002/cpt1976192148.

DOI:10.1002/cpt1976192148
PMID:4254
Abstract

The duration of the cardiac effects of single intravenous doses of the beta-antagonists, timolol and propranolol, was compared in 6 healthy male subjects. Timolol and propranolol were given in doses of 1 mg and 10 mg, respectively, and at specified times after their administration, beta-blockade was assessed by the reduction of maximal exercise-induced tachycardia and by the inhibition of the chronotropic and inotropic effects of isoproterenol. Inotropic effects were measured by changes in the pre-ejection period of left ventricular systole obtained from systolic time intervals. There was no statistically significant difference in the timolol and propranolol time-courses of beta-blockade. The change in exercise-tachycardia was maximal 5 min after beta-antagonist infusion but dissipated rapidly so that no statistically significant change was observed 9 hr later. The chronotropic and inotropic effects of isoproterenol were almost completely antagonized for 11/2 hr after beta-antagonist infusion, and significant beta-blockade could be demonstrated 9 hr later. There was no difference in the time-course of the negative chronotropic and inotropic effects of either beta-antagonist.

摘要

相似文献

1
Duration of cardiac effects of timolol and propranolol.
Clin Pharmacol Ther. 1976 Feb;19(2):148-52. doi: 10.1002/cpt1976192148.
2
Comparison of cardiac effects of timolol and propranolol.
Clin Pharmacol Ther. 1975 Sep;18(3):278-86. doi: 10.1002/cpt1975183278.
3
Comparison of the inotropic and chronotropic effects of metoprolol and propranolol.美托洛尔与普萘洛尔的变力性和变时性效应比较。
J Clin Pharmacol. 1981 May-Jun;21(5-6):213-8. doi: 10.1002/j.1552-4604.1981.tb02550.x.
4
Comparison of disposition and effect of timolol and propranolol on exercise tachycardia.噻吗洛尔和普萘洛尔对运动性心动过速的处置及效果比较。
Eur J Clin Pharmacol. 1978 Nov 9;14(1):7-14. doi: 10.1007/BF00560252.
5
Timolol maleate, a new beta-adrenergic receptor blocking agent.马来酸噻吗洛尔,一种新型β-肾上腺素能受体阻滞剂。
Arch Int Pharmacodyn Ther. 1975 Feb;213(2):251-63.
6
Cardiovascular and beta-adrenergic blocking effects of timolol.噻吗洛尔的心血管及β-肾上腺素能阻断作用。
Eur J Pharmacol. 1976 Feb;35(2):235-43. doi: 10.1016/0014-2999(76)90225-9.
7
Plasma timolol levels and systolic time intervals.血浆噻吗洛尔水平与收缩期时间间期。
Clin Pharmacol Ther. 1980 Aug;28(2):159-66. doi: 10.1038/clpt.1980.145.
8
Evidence for cardiac beta 2-adrenoceptors in man.人类心脏β2肾上腺素能受体的证据。
Clin Pharmacol Ther. 1983 Apr;33(4):424-8. doi: 10.1038/clpt.1983.57.
9
Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.心得安和美多心安对人体产生的β-肾上腺素能拮抗作用的药效学研究。
J Clin Invest. 1973 Apr;52(4):747-54. doi: 10.1172/JCI107237.
10
Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.噻吗洛尔(一种新型β-肾上腺素能阻滞剂)的某些心血管效应。
Arch Int Pharmacodyn Ther. 1973 Sep;205(1):76-93.

引用本文的文献

1
The effectiveness and safety of topical β-receptor blocker in treating superficial infantile haemangiomas: A meta-analysis including 20 studies.外用β受体阻滞剂治疗婴幼儿浅表性血管瘤的有效性和安全性:一项纳入20项研究的Meta分析
Br J Clin Pharmacol. 2020 Feb;86(2):199-209. doi: 10.1111/bcp.14196. Epub 2020 Jan 17.
2
Efficacy of low-dose Sr-Y therapy combined with topical application of 0.5% timolol maleate solution for the treatment of superficial infantile hemangiomas.低剂量锶-钇疗法联合局部应用0.5%马来酸噻吗洛尔溶液治疗婴幼儿浅表性血管瘤的疗效
Exp Ther Med. 2015 Sep;10(3):1013-1018. doi: 10.3892/etm.2015.2609. Epub 2015 Jul 1.
3
A standard approach to compiling clinical pharmacokinetic data.
一种汇编临床药代动力学数据的标准方法。
J Pharmacokinet Biopharm. 1981 Feb;9(1):59-127. doi: 10.1007/BF01059343.
4
Relationships among timolol doses, plasma concentrations and beta-adrenoceptor blocking activity.噻吗洛尔剂量、血浆浓度与β-肾上腺素能受体阻断活性之间的关系。
Br J Clin Pharmacol. 1982 Nov;14(5):719-25. doi: 10.1111/j.1365-2125.1982.tb04963.x.
5
Plasma timolol levels after oral and intravenous administration.
Eur J Clin Pharmacol. 1978 Dec 18;14(6):431-4. doi: 10.1007/BF00716385.
6
Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.β-肾上腺素受体阻断药的临床药代动力学
Clin Pharmacokinet. 1976;1(4):233-63. doi: 10.2165/00003088-197601040-00001.